Seroprevalence of SARS-CoV-2 in Guilan Province, Iran, April 2020

• DOI: 10.3201/eid2702.201960
• Publication Date: 2020-12-21T23:37:16Z
• Authors: Maryam Shakiba; Maryam Nazemipour; Arsalan Salari; Fardin Mehrabian; Seyed Saeed H. Na...; Seyed Mahmoud Rez...; Zahra Ghasempour; Abtin Heidarzadeh; Mohammad Ali Mans...
• Keywords: Male; Family Characteristics; asymptomatic infections; seroprevalence; SARS-CoV-2; R; COVID-19; Infectious and parasitic diseases; RC109-216; Iran; Antibodies, Viral; COVID-19 Serological Testing; 3. Good health; 03 medical and health sciences; Cross-Sectional Studies; 0302 clinical medicine; coronavirus disease; Seroepidemiologic Studies; Research Letter; Medicine; Humans; Female; severe acute respiratory syndrome coronavirus 2

We determined the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an affected area in northern Iran in April 2020. Antibodies to SARS-CoV-2 were detected in 528 persons by using rapid tests. Adjusted prevalence of SARS-CoV-2 seropositivity was 22.2% (95% CI 16.4%-28.5%).